Compound Detail
CHEMBL2028850
ICATIBANT 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
N=C(N)NCCC[C@@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C[C@@H]2CCCC[C@@H]21
Basic Information
| ChEMBL ID | CHEMBL2028850 |
| Name | ICATIBANT |
| Phase | Approved |
| Structure Type | BOTH |
| InChI Key | QURWXBZNHXJZBE-SKXRKSCCSA-N |
| Therapeutic | ✓ Yes |
8
Targets
26
Activities
4
Assay Types
6
PK Parameters
20
Publications
2
Known Names
8
Indications
Molecular Properties
1304.5
MW (Da)
Drug Information
| Molecule Type | Protein |
| First Approval | 2008 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Angioedema Angioedemas, Hereditary Hypotension Heart Failure Joint Diseases Mitochondrial Diseases Severe Acute Respiratory Syndrome Severe Acute Respiratory Syndrome
ATC Classification
B06AC02
icatibant
Level 1: BLOOD AND BLOOD FORMING ORGANS
Level 2: OTHER HEMATOLOGICAL AGENTS
Activity Summary
IC50 10 meas. best 10.05
Ki 8 meas. best 10.6
Kd 7 meas. best 9.55
EC50 1 meas. best 4.55
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| B2 bradykinin receptor CHEMBL3157 | Ki | 10.6 | 9.97 | 0.0 | 5 |
| Unchecked CHEMBL612545 | Ki | 10.18 | 10.18 | 0.1 | 1 |
| B2 bradykinin receptor CHEMBL2501 | Ki | 10.11 | 10.11 | 0.1 | 1 |
| B2 bradykinin receptor CHEMBL4111 | IC50 | 10.05 | 9.478 | 0.1 | 5 |
| B2 bradykinin receptor CHEMBL4111 | Ki | 9.96 | 9.96 | 0.1 | 1 |
| B2 bradykinin receptor CHEMBL3157 | Kd | 9.55 | 9.295 | 0.3 | 2 |
| B2 bradykinin receptor CHEMBL2501 | Kd | 9.5 | 9.5 | 0.3 | 1 |
| B2 bradykinin receptor CHEMBL3157 | IC50 | 9.31 | 8.91 | 0.5 | 5 |
| Rattus norvegicus CHEMBL376 | Kd | 8.94 | 8.94 | 1.1 | 1 |
| Cavia porcellus CHEMBL369 | Kd | 8.7 | 8.7 | 2.0 | 1 |
| Homo sapiens CHEMBL372 | Kd | 8.2 | 8.19 | 6.3 | 2 |
| Mas-related G-protein coupled receptor member X2 CHEMBL5849 | EC50 | 4.55 | 4.55 | 28183.8 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| F | 97.0 | % | Homo sapiens |
| T1/2 | 6.0 | hr | Homo sapiens |
| T1/2 | 6.0 | hr | Rattus norvegicus |
| T1/2 | 6.0 | hr | Sus scrofa |
| T1/2 | 6.0 | hr | Sus scrofa |
| T1/2 | 1.4 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 9767643 | 10.1021/jm980300f | B2 bradykinin receptor | 3 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 8691478 | 10.1021/jm950716i | Rattus norvegicus | 2 |
| 8691478 | 10.1021/jm950716i | B2 bradykinin receptor | 2 |
| 15027853 | 10.1021/jm030159x | Cavia porcellus | 2 |
| 15027853 | 10.1021/jm030159x | B2 bradykinin receptor | 2 |
| 28288109 | 10.1038/nchembio.2334 | Mas-related G-protein coupled receptor member X2 | 2 |
| 10514288 | 10.1021/jm9901529 | B2 bradykinin receptor | 2 |
| 7636840 | 10.1021/jm00015a001 | B2 bradykinin receptor | 2 |
| 17551020 | 10.1073/pnas.0610811104 | Rattus norvegicus | 2 |
| 38691890 | 10.1016/j.ejmech.2024.116456 | ADMET | 2 |
| 9767642 | 10.1021/jm980214f | Cavia porcellus | 2 |
| 9767642 | 10.1021/jm980214f | B2 bradykinin receptor | 2 |
| 8691478 | 10.1021/jm950716i | Sus scrofa | 2 |
| 16504505 | 10.1016/j.bmcl.2006.01.125 | B2 bradykinin receptor | 2 |
| 10514289 | 10.1021/jm9901531 | B2 bradykinin receptor | 1 |
| 8388469 | 10.1021/jm00062a018 | Cavia porcellus | 1 |
| 8388469 | 10.1021/jm00062a018 | B2 bradykinin receptor | 1 |
| 10514288 | 10.1021/jm9901529 | Rattus norvegicus | 1 |
Data from ChEMBL 36 via Core Engine